ANI PHARMACEUTICALS, INC Variable Lease, Cost
ANI PHARMACEUTICALS, INC (ANIP) reported Variable Lease, Cost of $190.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-02-27
- ANI PHARMACEUTICALS, INC variable lease, cost for the quarter ending 2022-12-31 was $63.00K, a 250.00% increase year-over-year.
- ANI PHARMACEUTICALS, INC variable lease, cost for the quarter ending 2022-09-30 was $53.00K, a 488.89% increase year-over-year.
- ANI PHARMACEUTICALS, INC variable lease, cost for the quarter ending 2022-06-30 was $54.00K, a 315.38% increase year-over-year.
- ANI PHARMACEUTICALS, INC variable lease, cost for the quarter ending 2022-03-31 was $66.00K, a 842.86% increase year-over-year.
- ANI PHARMACEUTICALS, INC variable lease, cost for fiscal 2025 was $190.00K, a 27.20% decline from fiscal 2024.
- ANI PHARMACEUTICALS, INC variable lease, cost for fiscal 2024 was $261.00K, a 18.10% increase from fiscal 2023.
- ANI PHARMACEUTICALS, INC variable lease, cost for fiscal 2023 was $221.00K, a 6.36% decline from fiscal 2022.
- ANI PHARMACEUTICALS, INC variable lease, cost for fiscal 2022 was $236.00K, a 391.67% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $190.00K 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $261.00K 10-K · filed 2026-02-27 | |||
| 2023-12-31 | $221.00K 10-K · filed 2026-02-27 | |||
| 2022-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $116.00K derived: sum of 2 quarters · filed 2025-02-28 | $170.00K derived: sum of 3 quarters · filed 2025-02-28 | $236.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $53.00K 10-Q · filed 2022-11-09 | $107.00K derived: sum of 2 quarters · filed 2022-11-09 | $173.00K 10-Q · filed 2022-11-09 | $191.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $54.00K 10-Q · filed 2022-08-08 | $120.00K 10-Q · filed 2022-08-08 | $138.00K derived: sum of 3 quarters · filed 2024-02-29 | $147.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $66.00K 10-Q · filed 2022-05-10 | $84.00K derived: sum of 2 quarters · filed 2024-02-29 | $93.00K derived: sum of 3 quarters · filed 2024-02-29 | $106.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $27.00K derived: sum of 2 quarters · filed 2024-02-29 | $40.00K derived: sum of 3 quarters · filed 2024-02-29 | $48.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $9.00K 10-Q · filed 2022-11-09 | $22.00K derived: sum of 2 quarters · filed 2022-11-09 | $30.00K 10-Q · filed 2022-11-09 | $51.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $13.00K 10-Q · filed 2022-08-08 | $21.00K 10-Q · filed 2022-08-08 | $42.00K derived: sum of 3 quarters · filed 2022-08-08 | $57.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $7.00K 10-Q · filed 2022-05-10 | $29.00K derived: sum of 2 quarters · filed 2022-05-10 | $44.00K derived: sum of 3 quarters · filed 2022-05-10 | $58.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $37.00K derived: sum of 2 quarters · filed 2022-03-15 | $51.00K derived: sum of 3 quarters · filed 2022-03-15 | $66.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $15.00K 10-Q · filed 2021-11-01 | $29.00K derived: sum of 2 quarters · filed 2021-11-01 | $44.00K 10-Q · filed 2021-11-01 | $60.00K derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | $14.00K 10-Q · filed 2021-08-06 | $29.00K 10-Q · filed 2021-08-06 | $45.00K derived: sum of 3 quarters · filed 2021-08-06 | $48.00K derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $15.00K 10-Q · filed 2021-05-07 | $31.00K derived: sum of 2 quarters · filed 2021-05-07 | $34.00K derived: sum of 3 quarters · filed 2021-05-07 | $51.00K derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $19.00K derived: sum of 2 quarters · filed 2021-03-11 | $36.00K derived: sum of 3 quarters · filed 2021-03-11 | $60.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $3.00K 10-Q · filed 2020-11-05 | $20.00K derived: sum of 2 quarters · filed 2020-11-05 | $44.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $17.00K 10-Q · filed 2020-08-06 | $41.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $13.00K 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |